SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Care-plan review) — Leonard Nimoy

PatientLeonard Nimoy
Date of birth1943-03-26
IdentifiersMRN HR-ML017-SYN; SSN (made up) 000-17-6604
Document date2026-08-11
AuthorCarla Benedetti, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month COPD review. [S]

History of Present Illness

Mr. Nimoy returns for his six-month COPD review. He has kept up the home exercise program, walking about 15 minutes twice a day and doing his strength routine three times a week. He still walks about 300 meters before stopping and uses a wheelchair for long distances such as airports. He uses albuterol about twice a week and takes every maintenance dose. He has had no flare-up, antibiotic or prednisone course, emergency visit, or hospital stay since he started treatment. The summer heat made him more breathless on a few afternoons, and he walked in the early morning instead. [S]

ElementDetail
ExerciseHome program kept up; walks about 300 meters before stopping
Reliever useAlbuterol about twice a week
AdherenceAll maintenance doses taken
ExacerbationsNone in six months of treatment, and none in the past 12 months
TriggersHot afternoons; walks early in the day

Review of Systems

SystemResultFinding
RespiratoryPositiveBreathless after about 300 meters or a flight of stairs; little cough; no change in sputum
CardiovascularNegativeNo chest pain, palpitations, or ankle swelling
PsychiatricNegativeMood good

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two inhalations as needed for breathlessness (prescribed by his previous clinician; used once or twice most days before intake)Two inhalations every 4 hours as needed, with a spacerRespiratory tract route2025-09-15activeS
Tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations once dailyTwo inhalations once each morningRespiratory tract route2026-02-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-11Body height185cmS
2026-08-11Body weight81kgS
2026-08-11Body mass index (BMI) [Ratio]23.7kg/m2S
2026-08-11Systolic blood pressure128mm[Hg]S
2026-08-11Diastolic blood pressure74mm[Hg]S
2026-08-11Heart rate76/minS
2026-08-11Respiratory rate18/minS
2026-08-11Body temperature36.6CelS
2026-08-11Oxygen saturation in Arterial blood by Pulse oximetry94%S

Physical Exam

Vital signs recorded on 2026-08-11; see the Vital Signs section. [S]

SystemFinding
GeneralComfortable at rest
LungsReduced breath sounds with prolonged expiration; no wheeze or crackles
CardiovascularRegular rhythm at 76 per minute; no edema
Inhaler techniqueCorrect with his soft mist inhaler

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic obstructive pulmonary disease, GOLD 3 (severe airflow limitation), group B, confirmed on spirometry; synthetic modern classification linked to his publicly disclosed COPDactiveconfirmed J44.9S — Synthetic modern spirometric classification; the COPD diagnosis itself is D from his own public disclosure.
Former smoker, quit about 30 years ago through a cessation programactiveconfirmed Z87.891S — Synthetic modern entry linked to his public account of quitting smoking.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyCOPD Assessment Test (CAT)Every visitCompleted today14, stable
SurveymMRC dyspnea gradeEvery visitCompleted todayGrade 2, stable
SurveyExacerbation history and GOLD groupEvery visitCompleted todayNone in the past 12 months; group B
ExaminationPulse oximetryEvery visitCompleted today94 percent at rest on room air
Self-managementSmoking status and cessation supportEvery visitCompleted todayFormer smoker; no tobacco
ExaminationBMI and nutritional statusEvery visitCompleted todayBMI 23.7; weight stable
ExaminationInhaler technique and adherenceEvery visitCompleted todayCorrect; full adherence
ExaminationLong-term oxygen assessmentAs indicated: resting saturation 88 percent or less, confirmed twice at least three weeks apartNot indicatedResting saturation 94 percent
ReferralPulmonary rehabilitationEligibility reviewed yearly and after any hospital stayUp to dateCompleted in May; home program kept up
ExaminationSpirometryAt diagnosis, then at least yearly and with significant clinical changeUp to dateDue at the yearly review in February
SurveyMood and comorbidity screeningAt diagnosis and yearlyDueDue at the annual wellness visit in October
Medication safetyVaccination statusReviewed yearlyDueInfluenza and RSV vaccines planned for the annual wellness visit before the respiratory virus season; COVID-19 vaccine this autumn

Goal progress:

Guideline basis: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2025 report (2025); CMID: Clinical Monitoring Intelligence Database, chronic obstructive pulmonary disease monograph (2026); Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline (2023); Home Oxygen Therapy for Adults with Chronic Lung Disease: An Official American Thoracic Society Clinical Practice Guideline (2020); Adult Immunization Schedule by Age (2026)

Follow-up: Annual wellness visit in October. COPD review in about six months with spirometry, or the same day for any flare-up. Next scheduled visit 2026-10-06: subsequent annual wellness visit. [S]